Home208340 • KOSDAQ
add
PharmAbcine Inc
Previous close
₩2,915.00
Year range
₩2,520.00 - ₩3,970.00
Market cap
76.32B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.90B | 4,304.86% |
Operating expense | 1.22B | -19.44% |
Net income | -400.25M | 62.67% |
Net profit margin | -21.08 | 99.15% |
Earnings per share | — | — |
EBITDA | -938.29M | 25.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.61B | 270.88% |
Total assets | 61.86B | 191.51% |
Total liabilities | 14.14B | 145.71% |
Total equity | 47.72B | — |
Shares outstanding | 80.19M | — |
Price to book | 4.90 | — |
Return on assets | -4.79% | — |
Return on capital | -5.14% | — |
Cash Flow
Net change in cash
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -400.25M | 62.67% |
Cash from operations | -903.49M | 46.20% |
Cash from investing | -417.20M | -387.75% |
Cash from financing | 6.42B | 239.27% |
Net change in cash | 4.27B | 171.45% |
Free cash flow | -2.16B | 20.39% |
About
CEO
Founded
2008
Website
Employees
39
